GSK3B and chronic myelogenous leukemia, BCR-ABL1 positive: More recently, β-catenin activation coupled with GSK3β inactivation, has been demonstrated in chronic myeloid leukemia(CML) in blast crisis and precursor B-cell acute lymphoblastic leukemia(ALL)[50].